Found 230 results
2015
Kretzler M, Sedor JR.  2015.  Introduction: Precision Medicine for Glomerular Disease: The Road Forward.. Semin Nephrol. 35(3):209-11.
Brosius FC, He JCijiang.  2015.  JAK inhibition and progressive kidney disease.. Curr Opin Nephrol Hypertens. 24(1):88-95.
Subathra M, Korrapati M, Howell LA, Arthur JM, Shayman JA, Schnellmann RG, Siskind LJ.  2015.  Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.. Am J Physiol Renal Physiol. 309(3):F204-15.
Ma L, Shelness GS, Snipes JA, Murea M, Antinozzi PA, Cheng D, Saleem MA, Satchell SC, Banas B, Mathieson PW et al..  2015.  Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.. J Am Soc Nephrol. 26(2):339-48.
Pennathur S, Pasichnyk K, Bahrami NM, Zeng L, Febbraio M, Yamaguchi I, Okamura DM.  2015.  The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injury.. Am J Pathol. 185(8):2232-45.
Atkins KB, Seki Y, Saha J, Eichinger F, Charron MJ, Brosius FC.  2015.  Maintenance of GLUT4 expression in smooth muscle prevents hypertension-induced changes in vascular reactivity.. Physiol Rep. 3(2)
Reich HN, Sabelnykova VY, Boutros PC.  2015.  Matching Kidneys and Urines: Establishing Noninvasive Surrogates of Intrarenal Events in Primary Glomerulonephritis.. Semin Nephrol. 35(3):256-65.
Hicken MT, Gipson DS.  2015.  Matching the Genotype in Resolution: Innovative Ways of Phenotype Capture.. Semin Nephrol. 35(3):279-90.
Shaeib F, Khan SN, Ali I, Najafi T, Maitra D, Abdulhamid I, Saed GM, Pennathur S, Abu-Soud HM.  2015.  Melatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acid.. PLoS One. 10(3):e0120737.
Hur J, Dauch JR, Hinder LM, Hayes JM, Backus C, Pennathur S, Kretzler M, Brosius FC, Feldman EL.  2015.  The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes.. Diabetes. 64(9):3294-304.
Mathew AV, Zeng L, Byun J, Pennathur S.  2015.  Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis.. J Proteomics Bioinform. Suppl 14
Sas KM, Karnovsky A, Michailidis G, Pennathur S.  2015.  Metabolomics and diabetes: analytical and computational approaches.. Diabetes. 64(3):718-32.
Zhou T-B, Drummen GPC, Jiang Z-P, Li H-Y.  2015.  Methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism and diabetic nephropathy susceptibility in patients with type 2 diabetes mellitus.. Ren Fail. 37(8):1247-59.
Lai JY, Luo J, O'Connor C, Jing X, Nair V, Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D et al..  2015.  MicroRNA-21 in glomerular injury.. J Am Soc Nephrol. 26(4):805-16.
Li H-D, Omenn GS, Guan Y.  2015.  MIsoMine: a genome-scale high-resolution data portal of expression, function and networks at the splice isoform level in the mouse.. Database (Oxford). 2015:bav045.
Davidson A, Bethunaickan R, Berthier C, Sahu R, Zhang W, Kretzler M.  2015.  Molecular studies of lupus nephritis kidneys.. Immunol Res. 63(1-3):187-96.
Kikuchi M, Wickman L, Hodgin JB, Wiggins RC.  2015.  Podometrics as a Potential Clinical Tool for Glomerular Disease Management.. Semin Nephrol. 35(3):245-55.
Zhu F, Shi L, Engel JDouglas, Guan Y.  2015.  Regulatory network inferred using expression data of small sample size: application and validation in erythroid system.. Bioinformatics. 31(15):2537-44.
Hou G, Wu V, Singh G, Holzman LB, Tsui CC.  2015.  Ret is critical for podocyte survival following glomerular injury in vivo.. Am J Physiol Renal Physiol. 308(7):F774-83.
Fan Y, Xiao W, Li Z, Li X, Chuang PY, Jim B, Zhang W, Wei C, Wang N, Jia W et al..  2015.  RTN1 mediates progression of kidney disease by inducing ER stress.. Nat Commun. 6:7841.
Anderberg RJ, Meek RL, Hudkins KL, Cooney SK, Alpers CE, Leboeuf RC, Tuttle KR.  2015.  Serum amyloid A and inflammation in diabetic kidney disease and podocytes.. Lab Invest. 95(3):250-62.
Verma R, Venkatareddy M, Kalinowski A, Patel SR, Salant DJ, Garg P.  2015.  Shp2 Associates with and Enhances Nephrin Tyrosine Phosphorylation and Is Necessary for Foot Process Spreading in Mouse Models of Podocyte Injury.. Mol Cell Biol. 36(4):596-614.
Yoo T-H, Pedigo CE, Guzman J, Correa-Medina M, Wei C, Villarreal R, Mitrofanova A, Leclercq F, Faul C, Li J et al..  2015.  Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.. J Am Soc Nephrol. 26(1):133-47.
Hogan MC, Lieske JC, Lienczewski CC, Nesbitt LL, Wickman LT, Heyer CM, Harris PC, Ward CJ, Sundsbak JL, Manganelli L et al..  2015.  Strategy and rationale for urine collection protocols employed in the NEPTUNE study.. BMC Nephrol. 16:190.
Sas KM, Nair V, Byun J, Kayampilly P, Zhang H, Saha J, Brosius FC, Kretzler M, Pennathur S.  2015.  Targeted Lipidomic and Transcriptomic Analysis Identifies Dysregulated Renal Ceramide Metabolism in a Mouse Model of Diabetic Kidney Disease.. J Proteomics Bioinform. Suppl 14

Pages